Canada markets closed

BioSyent Inc. (RX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
8.50+0.05 (+0.59%)
At close: 03:42PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
6,460
6,460
5,458
6,282
3,795
Depreciation & amortization
455.338
455.338
450.998
457.106
510.422
Deferred income taxes
-133.969
-133.969
-8.844
-68.246
-27.616
Stock based compensation
513.486
513.486
439.671
334.41
266.173
Change in working capital
-1,451
-1,451
-1,093
-2,175
2,494
Inventory
-1,482
-1,482
-2,437
-130.77
65.566
Accounts Payable
14.794
14.794
1,500
-160.352
942.592
Other working capital
4,881
4,881
4,429
4,582
6,720
Other non-cash items
-1,079
-1,079
-454.876
-76.193
-215.82
Net cash provided by operating activites
5,055
5,055
4,949
4,675
6,894
Cash flows from investing activities
Investments in property, plant and equipment
-174.23
-174.23
-519.317
-93.181
-174.298
Purchases of investments
-939.328
-2,500
-10,655
-4,890
-
Sales/Maturities of investments
2,629
2,629
-
-
-
Other investing activites
-11.538
158.766
192.759
-
-
Net cash used for investing activites
883.847
883.847
-10,790
-4,837
3,388
Cash flows from financing activities
Debt repayment
-174.055
-174.055
-161.812
-151.949
-144.253
Common stock repurchased
-3,253
-3,253
-3,689
-1,849
-3,142
Dividends Paid
-1,913
-1,913
-483.958
0
0
Other financing activites
-443.472
-443.472
-
-
-
Net cash used privided by (used for) financing activities
-5,785
-5,785
-4,371
-2,076
-3,372
Net change in cash
119.975
119.975
-10,171
-2,256
6,850
Cash at beginning of period
7,865
7,865
18,035
20,291
13,442
Cash at end of period
7,985
7,985
7,865
18,035
20,291
Free Cash Flow
Operating Cash Flow
5,055
5,055
4,949
4,675
6,894
Capital Expenditure
-174.23
-174.23
-519.317
-93.181
-174.298
Free Cash Flow
4,881
4,881
4,429
4,582
6,720